These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30200783)

  • 21. Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies.
    Shadid M; Shrestha A; Malik P
    PLoS One; 2024; 19(7):e0306719. PubMed ID: 38976688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies.
    Daniel-Moreno A; Lamsfus-Calle A; Wilber A; Chambers CB; Johnston I; Antony JS; Epting T; Handgretinger R; Mezger M
    Blood Cells Mol Dis; 2020 Sep; 84():102456. PubMed ID: 32498026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advance on genome editing for therapy of β-hemoglobinopathies.
    Liu JW; Hong T; Qin X; Liang YM; Zhang P
    Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward gene therapy for disorders of globin synthesis.
    Tisdale J; Sadelain M
    Semin Hematol; 2001 Oct; 38(4):382-92. PubMed ID: 11605174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.
    Venkatesan V; Srinivasan S; Babu P; Thangavel S
    Mol Cell Biol; 2020 Dec; 41(1):. PubMed ID: 33077498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.
    Emery DW; Stamatoyannopoulos G
    Ann N Y Acad Sci; 1999 Apr; 872():94-107; discussion 107-8. PubMed ID: 10372114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing approaches to β-hemoglobinopathies.
    Brusson M; Miccio A
    Prog Mol Biol Transl Sci; 2021; 182():153-183. PubMed ID: 34175041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies.
    Drysdale CM; Nassehi T; Gamer J; Yapundich M; Tisdale JF; Uchida N
    Cell Stem Cell; 2021 Feb; 28(2):191-208. PubMed ID: 33545079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
    Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
    Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for the hemoglobin disorders.
    Persons DA; Tisdale JF
    Semin Hematol; 2004 Oct; 41(4):279-86. PubMed ID: 15508113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Therapy and Genome Editing.
    Boulad F; Mansilla-Soto J; Cabriolu A; Rivière I; Sadelain M
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):329-342. PubMed ID: 29458735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by
    Koniali L; Flouri C; Kostopoulou MI; Papaioannou NY; Papasavva PL; Naiisseh B; Stephanou C; Demetriadou A; Sitarou M; Christou S; Antoniou MN; Kleanthous M; Patsali P; Lederer CW
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Globin vector regulatory elements are active in early hematopoietic progenitor cells.
    Cabriolu A; Odak A; Zamparo L; Yuan H; Leslie CS; Sadelain M
    Mol Ther; 2022 Jun; 30(6):2199-2209. PubMed ID: 35247584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell engineering for the treatment of severe hemoglobinopathies.
    Sadelain M; Boulad F; Lisowki L; Moi P; Riviere I
    Curr Mol Med; 2008 Nov; 8(7):690-7. PubMed ID: 18991654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.
    Sadelain M
    J Gene Med; 2002; 4(2):113-21. PubMed ID: 11933212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Droplet digital polymerase chain reaction-based quantitation of therapeutic lentiviral vector copies in transduced hematopoietic stem cells.
    Phuphanitcharoenkun S; Bhukhai K; Phanthong P; Prasongtanakij S; Linn AK; Sutjarit N; Anurathapan U; Leboulch P; Payen E; Hongeng S; Borwornpinyo S
    Cytotherapy; 2024 Jun; 26(6):586-591. PubMed ID: 38551525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
    Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
    Perumbeti A; Malik P
    Ann N Y Acad Sci; 2010 Aug; 1202():36-44. PubMed ID: 20712770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
    Dong AC; Rivella S
    Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside.
    Locatelli F; Cavazzana M; Frangoul H; Fuente J; Algeri M; Meisel R
    Mol Ther; 2024 May; 32(5):1202-1218. PubMed ID: 38454604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.